Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › VLP-based vaccines for targeting Staphylococcus aureus secreted virulence factors

VLP-based vaccines for targeting Staphylococcus aureus secreted virulence factors

US Patent 10821167 · Granted Nov 3, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Malaria immunogen and methods for using same2024
Malaria immunogen and methods for using same2024
Compositions targeting apoptosis-associated speck-like protein with caspase acti2024
Malaria immunogen and methods for using same2024
Malaria immunogen and methods for using same2024
Compositions comprising a PCSK9 peptide conjugated to a qbeta carrier and method2023
Compositions and methods for reducing serum triglycerides2023
EGFRvIII immunogen and methods for using same2022
Composition comprising PCSK9 peptide conjugated to a Qbeta carrier and methods o2021
Inhibition and treatment of bacterial infections by sex-specific GPER targeting2020
PCSK9 peptide vaccine conjugated to a Qbeta carrier and methods of using the sam2019
Compositions and methods for treating MRSA infections and for sensitizing MRSA t2018